Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03300505
Title ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer
Recruitment Suspended
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center

prostate adenocarcinoma


AZD5312 + Enzalutamide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.